Mycobacterial Diseases
Open Access

Investigating the Impact of Host Genetics on Tuberculosis Vulnerability

Jacques Fallu^{* *}Correspondence: Jacques Fallu, Department of Internal Medicine, Vaccine Research Group, Mayo Clinic of Education, Rochester, USA, Email:

Author info »

Description

Tuberculosis (TB) remains a global health concern, with millions of new cases reported each year. While TB is caused by Mycobacterium tuberculosis, not everyone exposed to the bacterium becomes infected or develops the disease. This variation in susceptibility has long intrigued scientists and researchers, leading to investigations into the role of host genetics in TB susceptibility [1].

The genetic basis of tuberculosis susceptibility

Tuberculosis is a complex disease influenced by multiple factors, including environmental, immunological, and genetic components. Among these factors, host genetics play a significant role in determining an individual's susceptibility to TB. Several genetic factors have been implicated in TB susceptibility, but one of the most well studied is the NRAMP1 (Natural Resistance-Associated Macrophage Protein 1) gene [2].

The NRAMP1 gene and TB susceptibility

The NRAMP1 gene encodes a protein involved in the regulation of iron transport in macrophages, which are immune cells that play a important role in the body's defense against TB. Studies have shown that certain variants of the NRAMP1 gene are associated with increased susceptibility to TB. Individuals carrying these variants may have impaired macrophage function, making it more difficult for their immune systems to control the Mycobacterium tuberculosis infection [3].

Another gene associated with TB susceptibility is the Interleukin-1 (IL-1) gene cluster. IL-1 is a cytokine that plays a key role in the inflammatory response to infection. Variations in the IL-1 gene cluster have been linked to differences in the production of IL-1, which can affect an individual's ability to mount an effective immune response against TB [4].

Additionally, genetic variations in Toll-Like Receptors (TLRs), which are essential for recognizing and responding to bacterial infections, have been investigated in the context of TB susceptibility. Variants in TLR genes can influence an individual's ability to detect and respond to Mycobacterium tuberculosis, potentially affecting their susceptibility to infection [5].

The HLA region and TB susceptibility

The Human Leukocyte Antigen (HLA) region, also known as the Major Histocompatibility Complex (MHC), is a group of genes that plays a crucial role in the immune system's ability to recognize and respond to pathogens. Variations in HLA genes have been associated with differential susceptibility to TB. Some HLA alleles are linked to increased susceptibility, while others are associated with protection against TB [6]. One well-known example is the HLA-DRB115:01 allele, which has been associated with increased susceptibility to TB in certain populations. Conversely, the HLA-DRB107:01 allele has been linked to protection against TB in some populations. These findings highlight the complex interplay between host genetics and TB susceptibility [7].

Population diversity and genetic variability

It is important to note that the relationship between genetics and TB susceptibility is not uniform across all populations. Different genetic backgrounds and environmental factors can lead to variations in susceptibility patterns. For example, a genetic variant that increases susceptibility to TB in one population may have a protective effect in another [8]. Furthermore, TB susceptibility is likely influenced by multiple genetic factors, making it a polygenic trait. Researchers continue to identify and study additional genetic variants that may contribute to TB susceptibility, further underscoring the complexity of this relationship.

Genetic factors in TB progression

In addition to susceptibility, host genetics can also influence the progression and severity of TB disease. Some genetic factors are associated with a higher risk of developing active TB after infection, while others may influence the response to TB treatment. Understanding these genetic factors can have important implications for personalized treatment approaches [9].

Future directions in TB research

The study of host genetics in TB susceptibility is a rapidly evolving field, with ongoing research aimed at uncovering new genetic factors and improving our understanding of their mechanisms of action. Advanced genomic technologies, such as Genome-Wide Association Studies (GWAS), are helping identify novel genetic variants associated with TB susceptibility [10]. Furthermore, as our understanding of the human immune system and its interactions with Mycobacterium tuberculosis deepens, we may uncover new pathways and targets for therapeutic interventions. Personalized medicine approaches that consider an individual’s genetic profile may become increasingly relevant in the treatment and prevention of TB.

Conclusion

The role of host genetics in TB susceptibility is a complex and multifaceted topic. While significant progress has been made in identifying genetic factors associated with TB susceptibility, much work remains to be done. It is clear that genetic variability plays a important role in determining an individual's risk of TB infection and disease progression. Understanding the genetic basis of TB susceptibility is not only of scientific interest but also of holds assured for the development of more targeted and effective prevention and treatment strategies. As research in this field continues to advance, we can hope for more personalized approaches to combat TB, ultimately contributing to the global effort to eliminate this crushing disease.

References

1. Bellamy R. Susceptibility to mycobacterial infections: The importance of host genetics. Genes Immun. 2003;4(1):4-11. [Google Scholar] [Pub Med] [Cross Ref]
2. Newport MJ, Finan C. Genome-wide association studies and susceptibility to infectious diseases. Brief Funct Genomics. 2011;10(2):98-107. [Google Scholar] [Pub Med] [Cross Ref]
3. Allen AR, Minozzi G, Glass EJ, Skuce RA, McDowell SW, Woolliams JA, et al. Bovine tuberculosis: The genetic basis of host susceptibility. Proc R Soc B Biol Sci. 2010;277(1695):2737-2745. [Google Scholar] [Pub Med] [Cross Ref]
4. Roodgar M. Host genetic susceptibility to tuberculosis in non-human primates. University of California, Davis ProQuest Dissertations Publishing. 2014;3646383. [Google Scholar]
5. Qu HQ, Fisher-Hoch SP, McCormick JB. Knowledge gaining by human genetic studies on tuberculosis susceptibility. J. Hum. Genet. 2011;56(3):177-182. [Google Scholar] [Pub Med] [Cross Ref]
6. Frodsham AJ. Host genetics and the outcome of Hepatitis B viral infection. Transpl. Immunol. 2005;14(3-4):183-186. [Google Scholar] [Pub Med] [Cross Ref]
7. Choi EH, Zimmerman PA, Foster CB, Zhu S, Kumaraswami V, Nutman TB, et al. Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun. 2001;2(5):248-253. [Google Scholar] [Pub Med] [Cross Ref]
8. Abel L, Fellay J, Haas DW, Schurr E, Srikrishna G, Urbanowski M, et al. Genetics of human susceptibility to active and latent tuberculosis: Present knowledge and future perspectives. Lancet Infect. Dis. 2018;18(3):e64-75. [Google Scholar] [Pub Med] [Cross Ref]
9. Tsairidou S, Anacleto O, Woolliams JA, Doeschl-Wilson A. Enhancing genetic disease control by selecting for lower host infectivity and susceptibility. J. Hered. 2019;122(6):742-758. [Google Scholar] [Pub Med] [Cross Ref]
10. LoPresti M, Beck DB, Duggal P, Cummings DA, Solomon BD. The role of host genetic factors in coronavirus susceptibility: Review of animal and systematic review of human literature. Am. J. Hum. Genet. 2020;107(3):381-402. [Google Scholar] [Pub Med] [Cross Ref]